Opsona Therapeutics' Series C - II Round

Opsona Therapeutics raised a round of funding on October 02, 2013. Investors include Omnes Capital.

Opsona Therapeutics is an immunology drug development company, focused on therapeutic approaches to key targets of the innate immune system associated with a wide range of major human diseases, includ…

Articles about Opsona Therapeutics' Series C - II Round: